Delivery Order SPE2DB22D2211-SPE2DB25FSEFL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,444.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $16,325.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,094.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $1,088.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, and this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors with an ultimate completion date of November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Mounjaro...
- The Defense Logistics Agency awarded a $2,777.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 8, 2025, with completion targeted for September 9, 2025. This delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,932.91 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors with a completion date of September 12, 2025. This competitively awarded, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing one component of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $9,747.92 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectables on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent with...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEFLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,820.52 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill open competition requirements across multiple therapeutic domains and transaction values positions it as a key supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 9/4/25 |